PP242 ≥98% mTOR inhibitor

Potent, selective and ATP-competitive mTOR inhibitor (IC₅₀ =8 nM). Inhibits both mTORC1 and mTORC2. Activates ERK via TORC1/eIF-4E/RAF pathway in cancer cells. Selective for mTOR over PI3K family kinases (IC₅₀ values are 0,1 (p110γ), 0,41 (DNA-PK), 1,27 (p110δ), 1,96 (p110α) and 2,2 (p110β) μM). Anticancer agent. Active in vivoand in vitro.

 : All products are FOR RESEARCH USE ONLY. PRODUCTS ARE NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES. Customer is granted a limited use non-exclusive licence for its own internal research. Any control manufacturer supplies with a Product is limited to use only to validate the relevant Product. By using the Product, Customers agree not to attempt to reverse engineer or otherwise perform any compositional, structural, functional or other analyses directed to learning the methodology, formulae, sequences, processes, make-up or production of any of the Products or portions thereof.